The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
NCT01202305 is an observational study sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies HIV. The registry lists an enrollment of 50 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2011 and a primary completion date of 30 Apr 2030. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01202305 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | University of California, San Francisco |
| Enrollment | 50 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | HIV |
| Start | 30 Apr 2011 |
| Primary completion | 30 Apr 2030 |
| Study completion | 30 Apr 2030 |
| Last update posted | 1 May 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01202305
Each answer restates registry values shown on this page.
What is NCT01202305?
NCT01202305 is an observational study sponsored by University of California, San Francisco. It studies HIV.
Is NCT01202305 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT01202305?
The registry names Steven Deeks, MD (principal investigator, University of California, San Francisco) as the overall official.
Where does NCT01202305 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT01202305 expected to complete?
The registry lists a primary completion date of 30 Apr 2030 and a study completion date of 30 Apr 2030. The sponsor last updated the record on 1 May 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.